Interview
Q&A: North Summit Capital's Wanli Min
Previously chief machine intelligence scientist at Alibaba Cloud, Wanli Min is now applying his deep technology expertise to investment at North Summit Capital. He explains what kind of innovation makes him tick
The crystal ball: Predictions for 2021
Industry professionals process the upheavals of 2020 to inform outlooks for a range of markets and investment themes. Realist bullishness abounds
Q&A: Hamilton Lane's Collwyn Tan
Collwyn Tan, Hamilton Lane’s co-head of Asia investment and key point person for everything transactional in the region, unpacks the mixed signals of 2020
LP interview: Rockefeller University
Rockefeller University has aggressively expanded its endowment program by ramping up its appetite for risk. Asian venture capital is playing a key role in this agenda
Profile: Aavishkaar's Vineet Rai
Vineet Rai’s career in impact investing started before the concept really existed. Spurred – but also slightly troubled – by mainstream awareness, he has big plans for India-based Aavishkaar Group
Q&A: British Columbia Investment's Jim Pittman
Jim Pittman, global head of private equity at British Columbia Investment Management, discusses the mechanics of building a co-investment heavy portfolio from Canada’s 12th largest urban center
Q&A: The Carlyle Group's Kewsong Lee
Kewsong Lee, CEO of The Carlyle Group, discusses the firm’s response to COVID-19, finding alpha in a low growth world, not allowing size to inhibit speed of action, and embracing work-from-home
Q&A: Investcorp's Duncan Zheng
Duncan Zheng, head of China private equity at Investcorp, observes that COVID-19 dislocation has created some timely inroads as the firm’s broader expansion agenda ramps up
LP interview: Hermes GPE
Hermes GPE is leaning into Asia as the region proves relatively successful in deflecting COVID-19. This entails a greater focus on growth capital, country funds, and defensive sector targeting
Profile: Jihoon Rim
Jihoon Rim has been a venture capitalist, CEO of one of Korea’s largest technology companies, and a US business school professor – in the space of a decade. He explains the appeal of new challenges
Q&A: Unison Capital's Tatsuo Kawasaki
Tatsuo Kawasaki, a partner at Unison Capital, on supporting existing investments and making new ones, expectations of distress in Japan, and why a platform approach makes sense for healthcare
LP interview: Canada Pension Plan Investment Board
For Canada Pension Plan Investment Board, COVID-19 has reinforced the key tenets of its Asia investment strategy, from being flexible on timeline to putting boots on the ground
Q&A: Starquest Capital's Frankie Fang
Frankie Fang, founding managing partner of China-focused fund-of-funds Starquest Capital, discusses early-stage valuations, specialization among domestic managers, and renminbi fundraising
Q&A: Hong Kong Monetary Authority's Anson Law
Hong Kong’s updated limited partnership ordinance came into force this week. Anson Law, a senior manager for market development at Hong Kong Monetary Authority, explains why it’s important for the territory
Q&A: ChrysCapital Partners' Sanjay Kukreja
Sanjay Kukreja, managing partner at India-focused ChrysCapital Partners, discusses timing, healthcare, technology, and why it makes sense to back entrepreneurs you’ve backed before
Start-up profiles: Sustainability agendas
Early-stage innovators across the region are leveraging both enterprise and consumer-facing models to address sustainability challenges with one eye on rapid commercialization
Q&A: Circulate Capital's Rob Kaplan
Rob Kaplan is CEO of Singapore’s Circulate Capital, which is dedicated to reducing oceanic plastic pollution. Its $150 million debut fund is backed by the likes of Coca-Cola, PepsiCo, and Unilever
Q&A: PAI Partners' Cornelia Gomez
Cornelia Gomez, head of ESG and sustainability at PAI Partners and global coordinator for the International Climate Initiative, discusses carbon footprinting, scenario analysis, and regulation
Profile: CITIC Capital's Hanxi Zhao
CITIC Capital’s Hanxi Zhao cut her teeth with brands in China at Procter & Gamble more than 20 years ago. The market has since moved on, but the underlying message has not
Q&A: Novo Holdings' Amit Kakar
Having spent the past three years on healthcare buy-and-build platform Everlife Asia, Amit Kakar’s is joining life sciences investor Novo Holdings as regional head. He explains why now is the time to bet big on Asia
Q&A: Navegar's Honorio Poblador
Honorio Poblador, co-founder at Philippines-based Navegar, explains how his firm is positioning its second fund – newly closed at $197 million – in the face of the COVID-19 downturn
LP interview: FMO
Dutch impact investor FMO has maintained significant appetite for private equity and developing Asia with relatively few resources at its disposal. Fintech is the next frontier
Profile: Kejora Ventures' Sebastian Togelang
Looking for new business opportunities, Sebastian Togelang returned to Indonesia from Germany to invest in technology start-ups. He counsels entrepreneurs that it pays to be part of a larger platform
Q&A: Iron Pillar's Anand Prasanna
Anand Prasanna, a managing partner at Indian venture capital firm Iron Pillar, on building local companies that can be globally relevant, selling a GP stake, and the impact of COVID-19
